Targeting the epitope spreader Pep19 by naïve human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy

MLA

Sung-Jo Kim, et al. “Targeting the Epitope Spreader Pep19 by Naïve Human CD45RA+ Regulatory T Cells Dictates a Distinct Suppressive T Cell Fate in a Novel Form of Immunotherapy.” Journal of Periodontal & Implant Science, vol. 47, Jan. 2017, p. 292. EBSCOhost, https://doi.org/10.5051/jpis.2017.47.5.292.

APA

Sung-Jo Kim, Gil Sun Cha, Hyun-Joo Kim, So Youn Park, Jeom-Il Choi, Ji-Young Joo, Ju-Youn Lee, & Jeongae Lee. (2017). Targeting the epitope spreader Pep19 by naïve human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy. Journal of Periodontal & Implant Science, 47, 292. https://doi.org/10.5051/jpis.2017.47.5.292

Chicago

Sung-Jo Kim, Gil Sun Cha, Hyun-Joo Kim, So Youn Park, Jeom-Il Choi, Ji-Young Joo, Ju-Youn Lee, and Jeongae Lee. 2017. “Targeting the Epitope Spreader Pep19 by Naïve Human CD45RA+ Regulatory T Cells Dictates a Distinct Suppressive T Cell Fate in a Novel Form of Immunotherapy.” Journal of Periodontal & Implant Science 47 (January): 292. doi:10.5051/jpis.2017.47.5.292.